The experts at the Adaptive Clinical Trials Innovation Center work with clients to assist with the trial design, simulation and execution, develop adaptive trials software tools, and work
Under the agreement, OBT will use Potelligent Technology for the manufacturing, development and commercializing chosen ADCC programs from its pipeline of preclinical antibodies for oncology, which it has
The two programs were part of Sunesis multi-kinase inhibitor collaboration with Biogen Idec, which was signed in 2004. Further in 2010, Biogen Idec has out licensed all its
GliaMed will be eligible to receive up to 8,205 shares of newly designated Series E Preferred Stock, which would be convertible into approximately 20% of the company’s fully
The single-arm screening Phase 2 trial is being conducted at seven centres across Canada and will enroll up to 30 patients whose brain tumour is in first relapse
The study is designed to determine the safety and pharmacokinetics of multiple ascending oral doses of DB959Na in both male and female subjects. The study results are estimated
Phoenix is a PK/PD modeling software platform that includes a range of tools that can be used individually or together. Pharsight claims the advanced Phoenix will support Windows
Bioniche Pharma claims Octreotide Acetate Injection USP is the generic version of Novartis’ Sandostatin, indicated for the treatment of acromegaly. The injection was developed by Chemi and is
As per the terms of the agreement, Merck, through a subsidiary, will initiate a tender offer for all outstanding common stock of Inspireat a price of $5 per
Aragen Bioscience has received three subcontracts to produce and characteriza stable cell lines expressing antibodies against polio virus, pandemic influenza virus and Candida albicans, and to develop cell
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.